Raras
Buscar doenças, sintomas, genes...
Vitreorretinopatia
ORPHA:98668DOENÇA RARA

Esta é uma lista parcial das doenças e distúrbios oculares humanos.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Vitreorretinopatia é uma condição ocular rara que afeta o vítreo e a retina, podendo causar microftalmia, hemorragias e remanescentes gliais. Frequentemente associada a outras anomalias como calcificações ectópicas e problemas dentários, pode impactar o desenvolvimento infantil.

Pesquisas ativas
8 ensaios
50 total registrados no ClinicalTrials.gov
Publicações científicas
4.338 artigos
Último publicado: 2026 Apr 17
🏥
SUS: Sem cobertura SUSScore: 0%
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

👁️
Olhos
115 sintomas
🦴
Ossos e articulações
69 sintomas
🧠
Neurológico
46 sintomas
😀
Face
29 sintomas
🧬
Pele e cabelo
25 sintomas
❤️
Coração
18 sintomas

+ 176 sintomas em outras categorias

Características mais comuns

Microftalmia
Calcificação ectópica
Hemorragia ocular
Remanescentes gliais anteriores ao disco óptico
Agenesia dentária
Dificuldades alimentares na infância
551sintomas
Sem dados (551)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 551 características clínicas mais associadas, ordenadas por frequência.

MicroftalmiaMicrophthalmia
Calcificação ectópicaEctopic calcification
Hemorragia ocularHemorrhage of the eye
Remanescentes gliais anteriores ao disco ópticoGlial remnants anterior to the optic disc
Agenesia dentáriaTooth agenesis

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico4.338PubMed
Últimos 10 anos200publicações
Pico2025119 papers
Linha do tempo
2026Hoje · 2026🧪 1985Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

28 genes identificados com associação a esta condição.

FZD4Frizzled-4Disease-causing germline mutation(s) inModerado
FUNÇÃO

Receptor for Wnt proteins (PubMed:30135577). Most frizzled receptors are coupled to the beta-catenin (CTNNB1) canonical signaling pathway, which leads to the activation of disheveled proteins, inhibition of GSK-3 kinase, nuclear accumulation of beta-catenin (CTNNB1) and activation of Wnt target genes (PubMed:30135577). Plays a critical role in retinal vascularization by acting as a receptor for Wnt proteins and norrin (NDP) (By similarity). In retina, it can be activated by Wnt protein-binding a

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (8)
Ca2+ pathwayAsymmetric localization of PCP proteinsWNT5A-dependent internalization of FZD4Clathrin-mediated endocytosisCargo recognition for clathrin-mediated endocytosis
MECANISMO DE DOENÇA

Vitreoretinopathy, exudative 1

An autosomal dominant disorder of the retinal vasculature characterized by an abrupt cessation of growth of peripheral capillaries, leading to an avascular peripheral retina. This may lead to compensatory retinal neovascularization, which is thought to be induced by hypoxia from the initial avascular insult. New vessels are prone to leakage and rupture causing exudates and bleeding, followed by scarring, retinal detachment and blindness. Clinical features can be highly variable, even within the same family. Patients with mild forms of the disease are asymptomatic, and their only disease related abnormality is an arc of avascular retina in the extreme temporal periphery. In many ways the disease resembles retinopathy of prematurity but there is no evidence of prematurity or small birth weight in the patient history.

EXPRESSÃO TECIDUAL(Ubíquo)
Tecido adiposo
153.3 TPM
Adipose Visceral Omentum
118.7 TPM
Mama
83.3 TPM
Pulmão
72.9 TPM
Artéria coronária
62.9 TPM
OUTRAS DOENÇAS (4)
exudative vitreoretinopathy 1persistent hyperplastic primary vitreousexudative vitreoretinopathyretinopathy of prematurity
HGNC:4042UniProt:Q9ULV1
BMP4Bone morphogenetic protein 4Candidate gene tested inAltamente restrito
FUNÇÃO

Growth factor of the TGF-beta superfamily that plays essential roles in many developmental processes, including neurogenesis, vascular development, angiogenesis and osteogenesis (PubMed:31363885). Acts in concert with PTHLH/PTHRP to stimulate ductal outgrowth during embryonic mammary development and to inhibit hair follicle induction (By similarity). Initiates the canonical BMP signaling cascade by associating with type I receptor BMPR1A and type II receptor BMPR2 (PubMed:25868050, PubMed:800600

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (8)
Formation of the ureteric budGerm layer formation at gastrulationFormation of the nephric ductFormation of intermediate mesodermSpecification of the neural plate border
MECANISMO DE DOENÇA

Microphthalmia, syndromic, 6

A disease characterized by microphthalmia/anophthalmia associated with facial, genital, skeletal, neurologic and endocrine anomalies. Microphthalmia is a disorder of eye formation, ranging from small size of a single eye to complete bilateral absence of ocular tissues (anophthalmia). In many cases, microphthalmia/anophthalmia occurs in association with syndromes that include non-ocular abnormalities.

OUTRAS DOENÇAS (5)
microphthalmia with brain and digit anomaliesorofacial cleft 11renal agenesis, unilateralStickler syndrome
HGNC:1071UniProt:P12644
COL9A1Collagen alpha-1(IX) chainDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Structural component of hyaline cartilage and vitreous of the eye

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (2)
Collagen biosynthesis and modifying enzymesCollagen chain trimerization
MECANISMO DE DOENÇA

Multiple epiphyseal dysplasia 6

A generalized skeletal dysplasia associated with significant morbidity. Joint pain, joint deformity, waddling gait, and short stature are the main clinical signs and symptoms. Radiological examination of the skeleton shows delayed, irregular mineralization of the epiphyseal ossification centers and of the centers of the carpal and tarsal bones. Multiple epiphyseal dysplasia is broadly categorized into the more severe Fairbank and the milder Ribbing types. The Fairbank type is characterized by shortness of stature, short and stubby fingers, small epiphyses in several joints, including the knee, ankle, hand, and hip. The Ribbing type is confined predominantly to the hip joints and is characterized by hands that are normal and stature that is normal or near-normal.

OUTRAS DOENÇAS (4)
epiphyseal dysplasia, multiple, 6Stickler syndrome, type 4multiple epiphyseal dysplasia due to collagen 9 anomalyobsolete autosomal recessive Stickler syndrome
HGNC:2217UniProt:P20849
KCNJ13Inward rectifier potassium channel 13Disease-causing germline mutation(s) inRestrito
FUNÇÃO

Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it. Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages. The inward rectification is mainly due to the blockage of outward current by internal magnesium. KCNJ13 has a very low single channel conductance, low sensitivity to

LOCALIZAÇÃO

MembraneCell membrane

MECANISMO DE DOENÇA

Snowflake vitreoretinal degeneration

Developmental and progressive hereditary eye disorder that affects multiple tissues within the eye. Diagnostic features of SVD include fibrillar degeneration of the vitreous humor, early-onset cataract, minute crystalline deposits in the neurosensory retina, and retinal detachment.

EXPRESSÃO TECIDUAL(Tecido-específico)
Intestino delgado
21.4 TPM
Rim - Medula
1.3 TPM
Skin Not Sun Exposed Suprapubic
1.1 TPM
Tireoide
0.9 TPM
Skin Sun Exposed Lower leg
0.8 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (3)
Leber congenital amaurosis 16snowflake vitreoretinal degenerationLeber congenital amaurosis
HGNC:6259UniProt:O60928
ATOH7Transcription factor ATOH7Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Transcription factor that binds to DNA at the consensus sequence 5'-CAG[GC]TG-3' (PubMed:31696227). Dimerization with TCF3 isoform E47 may be required in certain situations (PubMed:31696227). Binds to gene promoters and enhancer elements, and thereby regulates a transcriptional program of retinal ganglion cell (RGC) determinant genes (By similarity). Although the exact mechanism is not certain, retinal transcription regulation by ATOH7 has a role in RGC determination and survival, photoreceptor

LOCALIZAÇÃO

NucleusPerikaryonCell projection, axon

MECANISMO DE DOENÇA

Persistent hyperplastic primary vitreous, autosomal recessive

A developmental eye malformation associated with microphthalmia, cataract, glaucoma, and congenital retinal non-attachment. It is due to failure of the primary vitreous to regress in utero, resulting in the presence of a retrolental fibrovascular membrane with persistence of the posterior portion of the tunica vasculosa lentis and hyaloid artery. Disease manifestations range from a trivial remnant of hyaloid vessels to a dense fibrovascular mass causing lens opacity and retinal detachment.

INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (3)
persistent hyperplastic primary vitreous, autosomal recessivepersistent hyperplastic primary vitreousanterior segment dysgenesis 7
HGNC:13907UniProt:Q8N100
CDKL5Cyclin-dependent kinase-like 5Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Mediates phosphorylation of MECP2 (PubMed:15917271, PubMed:16935860). May regulate ciliogenesis (PubMed:29420175)

LOCALIZAÇÃO

NucleusCytoplasm, cytoskeleton, cilium basal bodyCytoplasm, cytoskeleton, microtubule organizing center, centrosome

OUTRAS DOENÇAS (5)
developmental and epileptic encephalopathy, 2X-linked retinoschisisCDKL5 disorderearly-infantile DEE
HGNC:11411UniProt:O76039
POT1Protection of telomeres protein 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the telomerase ribonucleoprotein (RNP) complex that is essential for the replication of chromosome termini. Is a component of the double-stranded telomeric DNA-binding TRF1 complex which is involved in the regulation of telomere length by cis-inhibition of telomerase. Also acts as a single-stranded telomeric DNA-binding protein and thus may act as a downstream effector of the TRF1 complex and may transduce information about telomere maintenance and/or length to the telomere terminus

LOCALIZAÇÃO

NucleusChromosome, telomere

VIAS BIOLÓGICAS (10)
DNA Damage/Telomere Stress Induced SenescencePackaging Of Telomere EndsMeiotic synapsisInhibition of DNA recombination at telomereTelomere C-strand (Lagging Strand) Synthesis
MECANISMO DE DOENÇA

Tumor predisposition syndrome 3

An autosomal dominant disorder characterized by an increased risk for the development of various types of benign and malignant neoplasms throughout life, with age-dependent penetrance. Affected individuals can develop neoplasms involving epithelial, mesenchymal, and neuronal tissues, as well as lymphoid and myeloid cancers. The disorder is associated with elongated telomeres.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
22.7 TPM
Nervo tibial
15.9 TPM
Testículo
15.3 TPM
Cervix Ectocervix
13.7 TPM
Útero
13.5 TPM
OUTRAS DOENÇAS (7)
tumor predisposition syndrome 3pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 8cerebroretinal microangiopathy with calcifications and cysts 3oligodendroglioma
HGNC:17284UniProt:Q9NUX5
ZNF408Zinc finger protein 408Disease-causing germline mutation(s) inTolerante
FUNÇÃO

May be involved in transcriptional regulation

LOCALIZAÇÃO

Nucleus

MECANISMO DE DOENÇA

Vitreoretinopathy, exudative 6

An autosomal dominant form of exudative vitreoretinopathy, a form of exudative vitreoretinopathy, a disorder of the retinal vasculature characterized by an abrupt cessation of growth of peripheral capillaries, leading to an avascular peripheral retina. This may lead to compensatory retinal neovascularization, which is thought to be induced by hypoxia from the initial avascular insult. New vessels are prone to leakage and rupture causing exudates and bleeding, followed by scarring, retinal detachment and blindness. Clinical features can be highly variable, even within the same family. Patients with mild forms of the disease are asymptomatic, and their only disease related abnormality is an arc of avascular retina in the extreme temporal periphery.

EXPRESSÃO TECIDUAL(Ubíquo)
Skin Sun Exposed Lower leg
17.9 TPM
Útero
17.1 TPM
Skin Not Sun Exposed Suprapubic
15.7 TPM
Bladder
15.6 TPM
Fallopian Tube
15.5 TPM
OUTRAS DOENÇAS (4)
exudative vitreoretinopathy 6retinitis pigmentosa 72exudative vitreoretinopathyretinitis pigmentosa
HGNC:20041UniProt:Q9H9D4
PAK2Serine/threonine-protein kinase PAK 2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Serine/threonine protein kinase that plays a role in a variety of different signaling pathways including cytoskeleton regulation, cell motility, cell cycle progression, apoptosis or proliferation (PubMed:12853446, PubMed:16617111, PubMed:19273597, PubMed:19923322, PubMed:33693784, PubMed:7744004, PubMed:9171063). Acts as a downstream effector of the small GTPases CDC42 and RAC1 (PubMed:7744004). Activation by the binding of active CDC42 and RAC1 results in a conformational change and a subsequen

LOCALIZAÇÃO

CytoplasmNucleusCytoplasm, perinuclear regionMembrane

VIAS BIOLÓGICAS (10)
FCERI mediated MAPK activationVEGFA-VEGFR2 PathwayVEGFR2 mediated vascular permeabilitySema3A PAK dependent Axon repulsionMAPK6/MAPK4 signaling
MECANISMO DE DOENÇA

Knobloch syndrome 2

An autosomal dominant form of Knobloch syndrome characterized by high myopia, vitreoretinal degeneration, retinal detachment, occipital encephalocele or scalp lesions, and mild to severe psychomotor delay.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
67.9 TPM
Fibroblastos
59.2 TPM
Nervo tibial
49.5 TPM
Tecido adiposo
46.2 TPM
Adipose Visceral Omentum
41.3 TPM
OUTRAS DOENÇAS (2)
Knobloch syndrome 2Knobloch syndrome 1
HGNC:8591UniProt:Q13177
STN1CST complex subunit STN1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the CST complex proposed to act as a specialized replication factor promoting DNA replication under conditions of replication stress or natural replication barriers such as the telomere duplex. The CST complex binds single-stranded DNA with high affinity in a sequence-independent manner, while isolated subunits bind DNA with low affinity by themselves. Initially the CST complex has been proposed to protect telomeres from DNA degradation (PubMed:19854130). However, the CST complex ha

LOCALIZAÇÃO

NucleusChromosome, telomere

VIAS BIOLÓGICAS (2)
Polymerase switching on the C-strand of the telomereTelomere C-strand synthesis initiation
MECANISMO DE DOENÇA

Cerebroretinal microangiopathy with calcifications and cysts 2

An autosomal recessive, multisystemic disorder characterized by intrauterine growth retardation and, later in life, premature aging symptoms, including poor growth, graying hair, liver fibrosis, portal hypertension, esophageal varices, osteopenia, pancytopenia, hypocellular bone marrow, and vascular telangiectasia resulting in gastrointestinal bleeding. Brain calcifications and white matter changes are responsible for signs including spasticity, ataxia, or dystonia observed in some patients.

EXPRESSÃO TECIDUAL(Ubíquo)
Esôfago - Mucosa
53.6 TPM
Testículo
46.4 TPM
Pulmão
45.8 TPM
Linfócitos
34.8 TPM
Aorta
34.7 TPM
OUTRAS DOENÇAS (3)
cerebroretinal microangiopathy with calcifications and cysts 2idiopathic pulmonary fibrosisCoats plus syndrome
HGNC:26200UniProt:Q9H668
CTNNB1Catenin beta-1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Key downstream component of the canonical Wnt signaling pathway (PubMed:17524503, PubMed:18077326, PubMed:18086858, PubMed:18957423, PubMed:21262353, PubMed:22155184, PubMed:22647378, PubMed:22699938). In the absence of Wnt, forms a complex with AXIN1, AXIN2, APC, CSNK1A1 and GSK3B that promotes phosphorylation on N-terminal Ser and Thr residues and ubiquitination of CTNNB1 via BTRC and its subsequent degradation by the proteasome (PubMed:17524503, PubMed:18077326, PubMed:18086858, PubMed:189574

LOCALIZAÇÃO

CytoplasmNucleusCytoplasm, cytoskeletonCell junction, adherens junctionCell junctionCell membraneCytoplasm, cytoskeleton, microtubule organizing center, centrosomeCytoplasm, cytoskeleton, spindle poleSynapseCytoplasm, cytoskeleton, cilium basal body

VIAS BIOLÓGICAS (10)
Formation of the nephric ductSpecification of the neural plate borderSynthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)TCF dependent signaling in response to WNTTranscriptional Regulation by VENTX
MECANISMO DE DOENÇA

Colorectal cancer

A complex disease characterized by malignant lesions arising from the inner wall of the large intestine (the colon) and the rectum. Genetic alterations are often associated with progression from premalignant lesion (adenoma) to invasive adenocarcinoma. Risk factors for cancer of the colon and rectum include colon polyps, long-standing ulcerative colitis, and genetic family history.

EXPRESSÃO TECIDUAL(Ubíquo)
Cervix Endocervix
297.5 TPM
Cervix Ectocervix
257.8 TPM
Artéria tibial
233.5 TPM
Ovário
201.9 TPM
Cérebro - Hemisfério cerebelar
201.3 TPM
OUTRAS DOENÇAS (17)
hepatocellular carcinomasevere intellectual disability-progressive spastic diplegia syndromeovarian cancerpilomatrixoma
HGNC:2514UniProt:P35222
COL9A2Collagen alpha-2(IX) chainDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Structural component of hyaline cartilage and vitreous of the eye

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (2)
Collagen biosynthesis and modifying enzymesCollagen chain trimerization
MECANISMO DE DOENÇA

Multiple epiphyseal dysplasia 2

A generalized skeletal dysplasia associated with significant morbidity. Joint pain, joint deformity, waddling gait, and short stature are the main clinical signs and symptoms. Radiological examination of the skeleton shows delayed, irregular mineralization of the epiphyseal ossification centers and of the centers of the carpal and tarsal bones. Multiple epiphyseal dysplasia is broadly categorized into the more severe Fairbank and the milder Ribbing types. The Fairbank type is characterized by shortness of stature, short and stubby fingers, small epiphyses in several joints, including the knee, ankle, hand, and hip. The Ribbing type is confined predominantly to the hip joints and is characterized by hands that are normal and stature that is normal or near-normal.

OUTRAS DOENÇAS (4)
epiphyseal dysplasia, multiple, 2Stickler syndrome, type 5multiple epiphyseal dysplasia due to collagen 9 anomalyobsolete autosomal recessive Stickler syndrome
HGNC:2218UniProt:Q14055
DYNC1H1Cytoplasmic dynein 1 heavy chain 1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Cytoplasmic dynein 1 acts as a motor for the intracellular retrograde motility of vesicles and organelles along microtubules. Dynein has ATPase activity; the force-producing power stroke is thought to occur on release of ADP. Plays a role in mitotic spindle assembly and metaphase plate congression (PubMed:27462074)

LOCALIZAÇÃO

Cytoplasm, cytoskeleton

VIAS BIOLÓGICAS (10)
AggrephagyAmplification of signal from unattached kinetochores via a MAD2 inhibitory signalRHO GTPases Activate ForminsMitotic PrometaphaseEML4 and NUDC in mitotic spindle formation
MECANISMO DE DOENÇA

Charcot-Marie-Tooth disease, axonal, type 2O

An axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
147.9 TPM
Cérebro - Hemisfério cerebelar
140.0 TPM
Cerebelo
129.1 TPM
Nervo tibial
80.3 TPM
Artéria tibial
78.4 TPM
OUTRAS DOENÇAS (4)
autosomal dominant childhood-onset proximal spinal muscular atrophy without contracturesCharcot-Marie-Tooth disease axonal type 2Ointellectual disability, autosomal dominant 13autosomal dominant non-syndromic intellectual disability
HGNC:2961UniProt:Q14204
CAPN5Calpain-5Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Calcium-regulated non-lysosomal thiol-protease

LOCALIZAÇÃO

VIAS BIOLÓGICAS (1)
Degradation of the extracellular matrix
MECANISMO DE DOENÇA

Vitreoretinopathy, neovascular inflammatory

An autoimmune condition of the eye that sequentially mimics uveitis, retinitis pigmentosa, and proliferative diabetic retinopathy as it progresses to complete blindness. Patients present during the second or third decade of life with posterior uveitis and reduction of the electroretinogram b-wave. They become more symptomatic when cataracts, cystoid macular edema, and disk edema diminish visual acuity during the second stage. Severe vision loss begins during the third stage when proliferative retinal neovascularization and epiretinal membranes appear. There is an ongoing pigmentary retinal degeneration and peripheral visual field loss during all stages. In the fourth stage, proliferative vitreoretinopathy causes tractional retinal detachments at the macula and vitreous base. The fifth or end-stage disease is marked by phthisis.

INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (1)
CAPN5-related vitreoretinopathy
HGNC:1482UniProt:O15484
BEST1Bestrophin-1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Ligand-gated anion channel that allows the movement of anions across cell membranes when activated by calcium (Ca2+) (PubMed:11904445, PubMed:12907679, PubMed:18179881, PubMed:18400985, PubMed:19853238, PubMed:21330666, PubMed:26200502, PubMed:26720466, PubMed:35789156). Allows the movement of chloride and hydrogencarbonate (PubMed:11904445, PubMed:12907679, PubMed:18179881, PubMed:18400985, PubMed:19853238, PubMed:21330666, PubMed:26200502, PubMed:26720466, PubMed:35789156). Found in a partiall

LOCALIZAÇÃO

Cell membraneBasolateral cell membrane

VIAS BIOLÓGICAS (1)
Stimuli-sensing channels
MECANISMO DE DOENÇA

Macular dystrophy, vitelliform, 2

An autosomal dominant form of macular degeneration that usually begins in childhood or adolescence. VMD2 is characterized by typical 'egg-yolk' macular lesions due to abnormal accumulation of lipofuscin within and beneath the retinal pigment epithelium cells. Progression of the disease leads to destruction of the retinal pigment epithelium and vision loss.

VIAS REACTOME (1)
OUTRAS DOENÇAS (8)
vitelliform macular dystrophy 2retinitis pigmentosa 50autosomal dominant vitreoretinochoroidopathyautosomal recessive bestrophinopathy
HGNC:12703UniProt:O76090
RS1RetinoschisinDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Binds negatively charged membrane lipids, such as phosphatidylserine and phosphoinositides (By similarity). May play a role in cell-cell adhesion processes in the retina, via homomeric interaction between octamers present on the surface of two neighboring cells (PubMed:27114531). Required for normal structure and function of the retina (PubMed:19093009)

LOCALIZAÇÃO

SecretedCell membrane

MECANISMO DE DOENÇA

Retinoschisis juvenile X-linked 1

A vitreo-retinal dystrophy characterized by macular pathology and by splitting of the superficial layer of the retina. Macular changes are present in almost all cases. In the fundi, radially oriented intraretinal foveomacular cysts are seen in a spoke-wheel configuration, with the absence of foveal reflex in most cases. In addition, approximately half of cases have bilateral peripheral retinoschisis in the inferotemporal part of the retina. Aside from the typical fundus appearance, strabismus, nystagmus, axial hyperopia, defective color vision and foveal ectopy can be present. The most important complications are vitreous hemorrhage, retinal detachment, and neovascular glaucoma.

EXPRESSÃO TECIDUAL(Baixa expressão)
Pulmão
2.2 TPM
Brain Frontal Cortex BA9
1.4 TPM
Córtex cerebral
1.2 TPM
Brain Anterior cingulate cortex BA24
1.0 TPM
Brain Caudate basal ganglia
1.0 TPM
INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (1)
X-linked retinoschisis
HGNC:10457UniProt:O15537
VCANVersican core proteinDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

May play a role in intercellular signaling and in connecting cells with the extracellular matrix. May take part in the regulation of cell motility, growth and differentiation. Binds hyaluronic acid

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrixCell projection, cilium, photoreceptor outer segmentSecreted, extracellular space, extracellular matrix, interphotoreceptor matrixSecreted

VIAS BIOLÓGICAS (2)
Post-translational protein phosphorylationRegulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
MECANISMO DE DOENÇA

Wagner vitreoretinopathy

A rare vitreoretinopathy characterized by an optically empty vitreous cavity with fibrillary condensations and a preretinal avascular membrane. Other optical features include progressive chorioretinal atrophy, perivascular sheating, subcapsular cataract and myopia.

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
214.0 TPM
Artéria coronária
147.8 TPM
Artéria tibial
66.9 TPM
Fibroblastos
55.0 TPM
Pulmão
40.4 TPM
OUTRAS DOENÇAS (1)
Wagner disease
HGNC:2464UniProt:P13611
COL2A1Collagen alpha-1(II) chainDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Type II collagen is specific for cartilaginous tissues. It is essential for the normal embryonic development of the skeleton, for linear growth and for the ability of cartilage to resist compressive forces

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (10)
Integrin cell surface interactionsMET activates PTK2 signalingDevelopmental Lineage of Pancreatic Ductal CellsAssembly of collagen fibrils and other multimeric structuresSignaling by PDGF
MECANISMO DE DOENÇA

Spondyloepiphyseal dysplasia congenital type

Disorder characterized by disproportionate short stature and pleiotropic involvement of the skeletal and ocular systems.

OUTRAS DOENÇAS (22)
Legg-Calve-Perthes diseasespondylometaphyseal dysplasia, Schmidt typeplatyspondylic dysplasia, Torrance typeKniest dysplasia
HGNC:2200UniProt:P02458
XYLT2Xylosyltransferase 2Disease-causing germline mutation(s) inRestrito
FUNÇÃO

Catalyzes the first step in the biosynthesis of chondroitin sulfate, heparan sulfate and dermatan sulfate proteoglycans, such as DCN. Transfers D-xylose from UDP-D-xylose to specific serine residues of the core protein

LOCALIZAÇÃO

Golgi apparatus membraneSecreted

VIAS BIOLÓGICAS (1)
Glycosaminoglycan-protein linkage region biosynthesis
MECANISMO DE DOENÇA

Spondyloocular syndrome

A syndrome characterized by cataract, loss of vision due to retinal detachment, facial dysmorphism, facial hypotonia, normal height with disproportional short trunk, osteoporosis, immobile spine with thoracic kyphosis and reduced lumbal lordosis.

EXPRESSÃO TECIDUAL(Ubíquo)
Estômago
113.7 TPM
Testículo
46.3 TPM
Ovário
29.4 TPM
Próstata
29.3 TPM
Cervix Endocervix
28.1 TPM
OUTRAS DOENÇAS (2)
spondylo-ocular syndromeautosomal recessive inherited pseudoxanthoma elasticum
HGNC:15517UniProt:Q9H1B5
NDPNorrinDisease-causing germline mutation(s) inRestrito
FUNÇÃO

Activates the canonical Wnt signaling pathway through FZD4 and LRP5 coreceptor. Plays a central role in retinal vascularization by acting as a ligand for FZD4 that signals via stabilizing beta-catenin (CTNNB1) and activating LEF/TCF-mediated transcriptional programs. Acts in concert with TSPAN12 to activate FZD4 independently of the Wnt-dependent activation of FZD4, suggesting the existence of a Wnt-independent signaling that also promote accumulation the beta-catenin (CTNNB1). May be involved i

LOCALIZAÇÃO

Secreted

VIAS BIOLÓGICAS (1)
Interconversion of nucleotide di- and triphosphates
MECANISMO DE DOENÇA

Norrie disease

Recessive disorder characterized by very early childhood blindness due to degenerative and proliferative changes of the neuroretina. Approximately 50% of patients show some form of progressive mental disorder, often with psychotic features, and about one-third of patients develop sensorineural deafness in the second decade. In addition, some patients have more complex phenotypes, including growth failure and seizure.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
40.0 TPM
Ovário
39.0 TPM
Cerebelo
34.9 TPM
Brain Caudate basal ganglia
30.1 TPM
Brain Frontal Cortex BA9
27.6 TPM
OUTRAS DOENÇAS (6)
Norrie diseaseexudative vitreoretinopathy 2, X-linkedpersistent hyperplastic primary vitreousCoats disease
HGNC:7678UniProt:Q00604
CTC1CST complex subunit CTC1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the CST complex proposed to act as a specialized replication factor promoting DNA replication under conditions of replication stress or natural replication barriers such as the telomere duplex. The CST complex binds single-stranded DNA with high affinity in a sequence-independent manner, while isolated subunits bind DNA with low affinity by themselves. Initially the CST complex has been proposed to protect telomeres from DNA degradation (PubMed:19854130). However, the CST complex ha

LOCALIZAÇÃO

NucleusChromosome, telomere

VIAS BIOLÓGICAS (2)
Polymerase switching on the C-strand of the telomereTelomere C-strand synthesis initiation
MECANISMO DE DOENÇA

Cerebroretinal microangiopathy with calcifications and cysts 1

An autosomal recessive pleiomorphic disorder characterized primarily by intracranial calcifications, leukodystrophy, and brain cysts, resulting in spasticity, ataxia, dystonia, seizures, and cognitive decline. Patients also have retinal telangiectasia and exudates (Coats disease) as well as extraneurologic manifestations, including osteopenia with poor bone healing and a high risk of gastrointestinal bleeding and portal hypertension caused by vasculature ectasias in the stomach, small intestine, and liver. Some individuals also have hair, skin, and nail changes, as well as anemia and thrombocytopenia.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
50.0 TPM
Cérebro - Hemisfério cerebelar
43.2 TPM
Baço
39.7 TPM
Cervix Endocervix
30.6 TPM
Útero
30.5 TPM
OUTRAS DOENÇAS (3)
cerebroretinal microangiopathy with calcifications and cysts 1dyskeratosis congenitaCoats plus syndrome
HGNC:26169UniProt:Q2NKJ3
COL18A1Collagen alpha-1(XVIII) chainDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Probably plays a major role in determining the retinal structure as well as in the closure of the neural tube May regulate extracellular matrix-dependent motility and morphogenesis of endothelial and non-endothelial cells; the function requires homotrimerization and implicates MAPK signaling Potently inhibits endothelial cell proliferation and angiogenesis (PubMed:9459295). May inhibit angiogenesis by binding to the heparan sulfate proteoglycans involved in growth factor signaling (By similarity

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrixSecreted, extracellular space, extracellular matrix, basement membraneSecreted

VIAS BIOLÓGICAS (1)
Assembly of collagen fibrils and other multimeric structures
MECANISMO DE DOENÇA

Knobloch syndrome 1

A developmental disorder primarily characterized by typical eye abnormalities, including high myopia, cataracts, dislocated lens, vitreoretinal degeneration, and retinal detachment, with occipital skull defects, which can range from occipital encephalocele to occult cutis aplasia.

OUTRAS DOENÇAS (2)
hereditary glaucoma, primary closed-angleKnobloch syndrome 1
HGNC:2195UniProt:P39060
NR2E3Photoreceptor-specific nuclear receptorDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Orphan nuclear receptor of retinal photoreceptor cells. Transcriptional factor that is an activator of rod development and repressor of cone development. Binds the promoter region of a number of rod- and cone-specific genes, including rhodopsin, M- and S-opsin and rod-specific phosphodiesterase beta subunit. Enhances rhodopsin expression. Represses M- and S-cone opsin expression

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (1)
Nuclear Receptor transcription pathway
MECANISMO DE DOENÇA

Enhanced S cone syndrome

Autosomal recessive retinopathy in which patients have increased sensitivity to blue light; perception of blue light is mediated by what is normally the least populous cone photoreceptor subtype, the S (short wavelength, blue) cones. ESCS is also associated with visual loss, with night blindness occurring from early in life, varying degrees of L (long, red)- and M (middle, green)-cone vision, and retinal degeneration.

EXPRESSÃO TECIDUAL(Baixa expressão)
Próstata
1.3 TPM
Testículo
1.2 TPM
Tireoide
1.0 TPM
Rim - Medula
0.7 TPM
Fallopian Tube
0.6 TPM
OUTRAS DOENÇAS (4)
enhanced S-cone syndromeretinitis pigmentosa 37Goldmann-Favre syndromeretinitis pigmentosa
HGNC:7974UniProt:Q9Y5X4
COL11A1Collagen alpha-1(XI) chainDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

May play an important role in fibrillogenesis by controlling lateral growth of collagen II fibrils

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (1)
Collagen biosynthesis and modifying enzymes
MECANISMO DE DOENÇA

Stickler syndrome 2

An autosomal dominant form of Stickler syndrome, an inherited disorder that associates ocular signs with more or less complete forms of Pierre Robin sequence, bone disorders and sensorineural deafness. Ocular disorders may include juvenile cataract, myopia, strabismus, vitreoretinal or chorioretinal degeneration, retinal detachment, and chronic uveitis. Pierre Robin sequence includes an opening in the roof of the mouth (a cleft palate), a large tongue (macroglossia), and a small lower jaw (micrognathia). Bones are affected by slight platyspondylisis and large, often defective epiphyses. Juvenile joint laxity is followed by early signs of arthrosis. The degree of hearing loss varies among affected individuals and may become more severe over time. Syndrome expressivity is variable.

OUTRAS DOENÇAS (8)
Marshall syndromeStickler syndrome type 2hearing loss, autosomal dominant 37fibrochondrogenesis 1
HGNC:2186UniProt:P12107
LRP5Low-density lipoprotein receptor-related protein 5Disease-causing germline mutation(s) inRestrito
FUNÇÃO

Acts as a coreceptor with members of the frizzled family of seven-transmembrane spanning receptors to transduce signal by Wnt proteins (PubMed:11336703, PubMed:11448771, PubMed:11719191, PubMed:15778503, PubMed:15908424, PubMed:16252235). Activates the canonical Wnt signaling pathway that controls cell fate determination and self-renewal during embryonic development and adult tissue regeneration (PubMed:11336703, PubMed:11719191). In particular, may play an important role in the development of t

LOCALIZAÇÃO

MembraneEndoplasmic reticulum

VIAS BIOLÓGICAS (1)
Negative regulation of TCF-dependent signaling by WNT ligand antagonists
MECANISMO DE DOENÇA

Vitreoretinopathy, exudative 1

An autosomal dominant disorder of the retinal vasculature characterized by an abrupt cessation of growth of peripheral capillaries, leading to an avascular peripheral retina. This may lead to compensatory retinal neovascularization, which is thought to be induced by hypoxia from the initial avascular insult. New vessels are prone to leakage and rupture causing exudates and bleeding, followed by scarring, retinal detachment and blindness. Clinical features can be highly variable, even within the same family. Patients with mild forms of the disease are asymptomatic, and their only disease related abnormality is an arc of avascular retina in the extreme temporal periphery. In many ways the disease resembles retinopathy of prematurity but there is no evidence of prematurity or small birth weight in the patient history.

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
83.2 TPM
Artéria tibial
67.8 TPM
Glândula salivar
64.2 TPM
Útero
56.7 TPM
Tireoide
51.4 TPM
OUTRAS DOENÇAS (12)
polycystic liver disease 4 with or without kidney cystsobsolete bone mineral density quantitative trait locus 1autosomal dominant osteosclerosis, Worth typeosteoporosis-pseudoglioma syndrome
HGNC:6697UniProt:O75197
IKBKGNF-kappa-B essential modulatorDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Regulatory subunit of the IKK core complex which phosphorylates inhibitors of NF-kappa-B thus leading to the dissociation of the inhibitor/NF-kappa-B complex and ultimately the degradation of the inhibitor (PubMed:14695475, PubMed:20724660, PubMed:21518757, PubMed:9751060). Its binding to scaffolding polyubiquitin plays a key role in IKK activation by multiple signaling receptor pathways (PubMed:16547522, PubMed:18287044, PubMed:19033441, PubMed:19185524, PubMed:21606507, PubMed:27777308, PubMed

LOCALIZAÇÃO

CytoplasmNucleus

VIAS BIOLÓGICAS (10)
SARS-CoV-2 activates/modulates innate and adaptive immune responsesNOD1/2 Signaling PathwayTAK1-dependent IKK and NF-kappa-B activation Interleukin-1 signalingJNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1
MECANISMO DE DOENÇA

Ectodermal dysplasia and immunodeficiency 1

A form of ectoderma dysplasia, a heterogeneous group of disorders due to abnormal development of two or more ectodermal structures. EDAID1 is an X-linked recessive disorder characterized by absence of sweat glands, sparse scalp hair, rare conical teeth and immunological abnormalities resulting in severe infectious diseases. Severely affected individuals may also show lymphedema, osteopetrosis, and, rarely, hematologic abnormalities. The phenotype is highly variable, and may be fatal in childhood.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
7.4 TPM
Sangue
7.3 TPM
Baço
7.2 TPM
Pulmão
7.0 TPM
Útero
6.7 TPM
OUTRAS DOENÇAS (6)
incontinentia pigmentiectodermal dysplasia and immunodeficiency 1autoinflammatory disease, X-linkedimmunodeficiency 33
HGNC:5961UniProt:Q9Y6K9
TSPAN12Tetraspanin-12Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Regulator of cell surface receptor signal transduction. Plays a central role in retinal vascularization by regulating norrin (NDP) signal transduction. Acts in concert with norrin (NDP) to promote FZD4 multimerization and subsequent activation of FZD4, leading to promote accumulation of beta-catenin (CTNNB1) and stimulate LEF/TCF-mediated transcriptional programs. Suprisingly, it only activates the norrin (NDP)-dependent activation of FZD4, while it does not activate the Wnt-dependent activation

LOCALIZAÇÃO

Cell membrane

MECANISMO DE DOENÇA

Vitreoretinopathy, exudative 5

An autosomal dominant form of exudative vitreoretinopathy, a disorder of the retinal vasculature characterized by an abrupt cessation of growth of peripheral capillaries, leading to an avascular peripheral retina. This may lead to compensatory retinal neovascularization, which is thought to be induced by hypoxia from the initial avascular insult. New vessels are prone to leakage and rupture causing exudates and bleeding, followed by scarring, retinal detachment and blindness. Clinical features can be highly variable, even within the same family. Patients with mild forms of the disease are asymptomatic, and their only disease related abnormality is an arc of avascular retina in the extreme temporal periphery.

EXPRESSÃO TECIDUAL(Ubíquo)
Glândula adrenal
48.0 TPM
Tireoide
36.6 TPM
Rim - Medula
31.7 TPM
Pulmão
29.9 TPM
Artéria tibial
28.1 TPM
INTERAÇÕES PROTEICAS (5)
OUTRAS DOENÇAS (2)
exudative vitreoretinopathy 5exudative vitreoretinopathy
HGNC:21641UniProt:O95859
COL9A3Collagen alpha-3(IX) chainDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Structural component of hyaline cartilage and vitreous of the eye

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (2)
Collagen biosynthesis and modifying enzymesCollagen chain trimerization
MECANISMO DE DOENÇA

Multiple epiphyseal dysplasia 3

A generalized skeletal dysplasia associated with significant morbidity. Joint pain, joint deformity, waddling gait, and short stature are the main clinical signs and symptoms. Radiological examination of the skeleton shows delayed, irregular mineralization of the epiphyseal ossification centers and of the centers of the carpal and tarsal bones. Multiple epiphyseal dysplasia is broadly categorized into the more severe Fairbank and the milder Ribbing types. The Fairbank type is characterized by shortness of stature, short and stubby fingers, small epiphyses in several joints, including the knee, ankle, hand, and hip. The Ribbing type is confined predominantly to the hip joints and is characterized by hands that are normal and stature that is normal or near-normal.

OUTRAS DOENÇAS (5)
Stickler syndrome, type 6epiphyseal dysplasia, multiple, 3multiple epiphyseal dysplasia due to collagen 9 anomalyobsolete autosomal recessive Stickler syndrome
HGNC:2219UniProt:Q14050

Variantes genéticas (ClinVar)

433 variantes patogênicas registradas no ClinVar.

🧬 FZD4: NM_012193.4(FZD4):c.568C>T (p.Gln190Ter) ()
🧬 FZD4: NM_012193.4(FZD4):c.1328del (p.Leu443fs) ()
🧬 FZD4: NM_012193.4(FZD4):c.1007del (p.Gly336fs) ()
🧬 FZD4: NM_012193.4(FZD4):c.14del (p.Gly5fs) ()
🧬 FZD4: NM_012193.4(FZD4):c.470T>A (p.Met157Lys) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 1,082 variantes classificadas pelo ClinVar.

487
595
Patogênica (45.0%)
VUS (55.0%)
VARIANTES MAIS SIGNIFICATIVAS
COL2A1: NM_001844.5(COL2A1):c.2957C>T (p.Pro986Leu) [Likely pathogenic]
COL2A1: NM_001844.5(COL2A1):c.2464-2A>T [Likely pathogenic]
LRP5: NM_002335.4(LRP5):c.2777G>A (p.Cys926Tyr) [Likely pathogenic]
FZD4: NM_012193.4(FZD4):c.1512G>A (p.Trp504Ter) [Likely pathogenic]
LRP6: G1309E [Pathogenic]

Vias biológicas (Reactome)

174 vias biológicas associadas aos genes desta condição.

Class B/2 (Secretin family receptors) Ca2+ pathway Asymmetric localization of PCP proteins Regulation of FZD by ubiquitination WNT5A-dependent internalization of FZD4 Signaling by RNF43 mutants Cargo recognition for clathrin-mediated endocytosis Clathrin-mediated endocytosis Molecules associated with elastic fibres Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) Post-translational protein phosphorylation Germ layer formation at gastrulation Formation of lateral plate mesoderm Formation of intermediate mesoderm Formation of paraxial mesoderm Specification of primordial germ cells Formation of the nephric duct Formation of the ureteric bud Specification of the neural plate border Collagen degradation Collagen biosynthesis and modifying enzymes Signaling by PDGF Assembly of collagen fibrils and other multimeric structures Integrin cell surface interactions ECM proteoglycans NCAM1 interactions Collagen chain trimerization Transcriptional Regulation by MECP2 Loss of function of MECP2 in Rett syndrome Regulation of MECP2 expression and activity Recognition and association of DNA glycosylase with site containing an affected pyrimidine Cleavage of the damaged pyrimidine Recognition and association of DNA glycosylase with site containing an affected purine Cleavage of the damaged purine Meiotic synapsis Packaging Of Telomere Ends Telomere Extension By Telomerase Polymerase switching on the C-strand of the telomere Processive synthesis on the C-strand of the telomere Telomere C-strand (Lagging Strand) Synthesis Telomere C-strand synthesis initiation Removal of the Flap Intermediate from the C-strand DNA Damage/Telomere Stress Induced Senescence Inhibition of DNA recombination at telomere Nef and signal transduction Generation of second messenger molecules Regulation of PAK-2p34 activity by PS-GAP/RHG10 Regulation of activated PAK-2p34 by proteasome mediated degradation Stimulation of the cell death response by PAK-2p34 FCERI mediated MAPK activation CD28 dependent Vav1 pathway Ephrin signaling Sema3A PAK dependent Axon repulsion Activation of RAC1 VEGFA-VEGFR2 Pathway Smooth Muscle Contraction VEGFR2 mediated vascular permeability CD209 (DC-SIGN) signaling RHO GTPases activate PAKs MAPK6/MAPK4 signaling Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation CDC42 GTPase cycle RAC1 GTPase cycle RAC2 GTPase cycle RHOQ GTPase cycle RHOH GTPase cycle RHOG GTPase cycle RHOJ GTPase cycle RHOU GTPase cycle RAC3 GTPase cycle RHOV GTPase cycle Degradation of beta-catenin by the destruction complex Beta-catenin phosphorylation cascade TCF dependent signaling in response to WNT Formation of the beta-catenin:TCF transactivating complex LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production Apoptotic cleavage of cell adhesion proteins Deactivation of the beta-catenin transactivating complex Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) Adherens junctions interactions Binding of TCF/LEF:CTNNB1 to target gene promoters Disassembly of the destruction complex and recruitment of AXIN to the membrane Myogenesis Signaling by GSK3beta mutants CTNNB1 S33 mutants aren't phosphorylated CTNNB1 S37 mutants aren't phosphorylated CTNNB1 S45 mutants aren't phosphorylated CTNNB1 T41 mutants aren't phosphorylated RHO GTPases activate IQGAPs Transcriptional Regulation by VENTX InlA-mediated entry of Listeria monocytogenes into host cells RUNX3 regulates WNT signaling Cardiogenesis Regulation of CDH11 function Regulation of CDH19 Expression and Function Regulation of CDH1 Function Degradation of CDH1 Regulation of CDH1 posttranslational processing and trafficking to plasma membrane Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal MHC class II antigen presentation Separation of Sister Chromatids Resolution of Sister Chromatid Cohesion Regulation of PLK1 Activity at G2/M Transition HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand Loss of Nlp from mitotic centrosomes Recruitment of mitotic centrosome proteins and complexes Loss of proteins required for interphase microtubule organization from the centrosome Recruitment of NuMA to mitotic centrosomes Anchoring of the basal body to the plasma membrane RHO GTPases Activate Formins Neutrophil degranulation COPI-mediated anterograde transport COPI-independent Golgi-to-ER retrograde traffic Mitotic Prometaphase AURKA Activation by TPX2 HCMV Early Events Aggrephagy EML4 and NUDC in mitotic spindle formation Degradation of the extracellular matrix Stimuli-sensing channels OCT2 mediates tubular secretion of organic cations in the kidney OCT2 mediates tubular uptake of organic cations in the kidney SLC5A1 cotransports Glc,Gal with Na+ from extracellular region to cytosol Glycosaminoglycan-protein linkage region biosynthesis CS-GAG biosynthesis DS-GAG biosynthesis CS/DS degradation Defective B4GALT7 causes EDS, progeroid type Defective B3GAT3 causes JDSSDHD Defective CHST3 causes SEDCJD Defective CHST14 causes EDS, musculocontractural type Defective CHSY1 causes TPBS Defective B3GALT6 causes EDSP2 and SEMDJL1 Fibronectin matrix formation Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell Non-integrin membrane-ECM interactions MET activates PTK2 signaling Developmental Lineage of Pancreatic Ductal Cells Interconversion of nucleotide di- and triphosphates Activation of Matrix Metalloproteinases Laminin interactions Nuclear Receptor transcription pathway Negative regulation of TCF-dependent signaling by WNT ligand antagonists Signaling by LRP5 mutants Activation of NF-kappaB in B cells ER-Phagosome pathway NOD1/2 Signaling Pathway TICAM1, RIP1-mediated IKK complex recruitment RIP-mediated NFkB activation via ZBP1 Downstream TCR signaling FCERI mediated NF-kB activation TAK1-dependent IKK and NF-kappa-B activation activated TAK1 mediates p38 MAPK activation JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 SUMOylation of immune response proteins Regulation of TNFR1 signaling TNFR1-induced NF-kappa-B signaling pathway IKBKB deficiency causes SCID IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) IkBA variant leads to EDA-ID CLEC7A (Dectin-1) signaling MAP3K8 (TPL2)-dependent MAPK1/3 activation Ub-specific processing proteases Ovarian tumor domain proteases Interleukin-1 signaling TRAF6 mediated NF-kB activation NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 IRAK1 recruits IKK complex IKK complex recruitment mediated by RIP1 SARS-CoV-2 activates/modulates innate and adaptive immune responses IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation Regulation of NF-kappa B signaling PKR-mediated signaling SLC15A4:TASL-dependent IRF5 activation

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
Aprovado1
3Fase 33
2Fase 28
1Fase 14
·Pré-clínico4
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 20 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Vitreorretinopatia

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

3 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

50 ensaios clínicos encontrados, 8 ativos.

Distribuição por fase
NCT05660447 · A Multi-Center Study on the Use of Rho-Kinase Inhibitor to R…Ativo
PHASE2, PHASE3
NCT07386678 · Study of Imaging and Molecular Biomarkers in Uncomplicated R…Em breve
NCT06425419 · The Safety and Efficacy of Intravitreal Topotecan for the Tr…Em breve
PHASE1
NCT06818721 · Intravitreal Topotecan for Prevention or Treatment of Prolif…Em breve
PHASE2
NCT05538156 · Internal Limiting Membrane Peeling in Retinal Detachment Sur…Em breve
NA
NCT07162818 · Effects of 0.1% Nepafenac on Vitreous Inflammatory Biomarker…Concluído
PHASE4
NCT05620901 · DEXTENZA in Pediatric Patients Following Retinal Surgery or …Concluído
EARLY_PHASE1
NCT04136366 · The GUARD Trial - Part 1: A Phase 3 Clinical Trial for Preve…Concluído
PHASE3
NCT06289205 · "Comparing Methotrexate Usage Techniques to Prevent Prolifer…UNKNOWN
PHASE1, PHASE2
NCT04891991 · Intravitreal Infliximab for Proliferative VitreoretinopathyConcluído
PHASE2
NCT06166914 · Efficacy of 5-fluorouracil and Low Molecular Weight Heparin …Concluído
NA
NCT03727776 · Adrenocorticotropic Hormone (ACTH) for Post-op Inflammation …Concluído
EARLY_PHASE1
NCT04830878 · Methotrexate For The Prevention and Treatment of Proliferati…Cancelado
PHASE1
NCT05561569 · Air Versus Gas Tamponade in Primary Retinal DetachmentUNKNOWN
NA
NCT04580147 · Intravitreal Aflibercept for the Prevention of Proliferative…UNKNOWN
PHASE2
NCT02834559 · Prophylactic Intravitreal 5-Fluorouracil and Heparin to Prev…Concluído
PHASE3
NCT02192970 · Bevacizumab Against Recurrent Retinal DetachmentConcluído
PHASE2
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
1.912 papers (10 anos)

Mostrando amostra de 200 publicações de um total de 1.912

#1

KIF11 prevents retinal endothelial ferroptosis in familial exudative vitreoretinopathy by inhibiting phosphorylation-driven PRDX1 phase separation.

Nature communications2026 Mar 24

Familial exudative vitreoretinopathy is a hereditary disorder predominantly affecting infants and young children, often leading to severe vision loss. Approximately 40% of patients carry mutations in Norrin/β-catenin pathway genes. Nevertheless, the downstream pathogenic mechanisms remain unclear. Here, by using bulk RNA sequencing and single-cell RNA sequencing analyses, we identify KIF11 as a key downstream effector in retinal endothelial cells. Lentivirus-mediated KIF11 overexpression partially restores vascular defects in endothelial cell-specific Ctnnb1 knockout mice. Functional and multi-omics studies reveal that β-catenin/KIF11 deficiency induces autophagy-accompanied ferroptosis. Mechanistically, KIF11 binds PRDX1, and the disrupted β-catenin/KIF11 axis releases the competitive restraint of KIF11 on Src-mediated PRDX1 phosphorylation, triggering subsequent liquid-liquid phase separation. Treatment with the ferroptosis inhibitor ferrostatin-1 or lentiviral overexpression of non-phosphorylatable PRDX1 partially rescues vascular defects in familial exudative vitreoretinopathy-associated mice. Overall, we elucidate a β-catenin/KIF11/PRDX1 axis-dependent ferroptosis mechanism in familial exudative vitreoretinopathy, highlighting ferroptosis-targeting and antioxidant strategies as potential therapies.

#2

The Inhibitory Effects of a Peripherally Restricted CB1 Receptor Antagonist on Myofibroblast Transdifferentiation of Human Retinal Pigment Epithelial Cells.

Cells2026 Feb 27

Myofibroblasts derived from retinal pigment epithelial (RPE) cells play a key role in the pathogenesis of retinal fibrotic conditions such as proliferative vitreoretinopathy (PVR). Upon exposure to growth factors and cytokines such as TNF-α and TGF-β (TNT), RPE cells undergo epithelial-mesenchymal transition and subsequent transdifferentiation to contractile myofibroblasts. In this study, the effects of JD5037, a peripherally restricted CB1 antagonist, on myofibroblast transdifferentiation of primary cultures of human RPE cells were assessed. JD5037 significantly reduced TNT-induced, RPE cell-mediated collagen gel contraction, an indicator of myofibroblast function, in a concentration-dependent manner. Western blot analysis showed that JD5037 attenuated TNT-induced expression of α-SMA and fibronectin, two molecular markers of myofibroblasts. Furthermore, siRNA knockdown of CB1 cannabinoid receptor partially inhibited TNT-induced myofibroblast transdifferentation of human RPE cells and eliminated the inhibitory effects of JD5037 on myofibroblast transdifferentiation. These data demonstrate, for the first time, that peripherally restricted antagonists, such as JD5037, targeting the CB1 cannabinoid receptor have therapeutic potential for PVR and other retinal fibrotic conditions.

#3

CTNNB1-related disorders: clinical and radiological contributions from a French cohort.

Frontiers in neurology2026

CTNNB1 monoallelic pathogenic variants account for up to 4% of genetically determined cerebral palsy cases, yet their phenotypic spectrum remains poorly defined. We retrospectively analyzed 25 individuals with pathogenic CTNNB1 variants using medical records and a questionnaire. Data included genetic variants, perinatal history, developmental milestones, behavioral characteristics, head growth, feeding, sleep difficulties, neurological and ophthalmological assessments. Brain MRIs were reviewed by expert neuroradiologists. Twenty-two distinct heterozygous variants were identified. Microcephaly occurred in 16/22 patients. All exhibited global developmental delay, independent walking was achieved at a mean age of 2.1 years, with regression in 4/16 independent walkers. Behavioral disorders were frequent, as were oral sensorimotor disorders (21/25) and sleep disturbances (13/21). Lower limb hypertonia was present in 22/25 patients [spastic (8) and/or dystonic (11)]. Unstable gait were common among ambulatory patients. Exaggerated startle reactions, often since birth, were reported in 16/21. Exudative vitreoretinopathy was identified in 3/5 patients with retinal angiography. Brain MRI (19 patients) showed: thickening of anterior commissure (8), frontal lobe hypoplasia (9), widening of superior vermian sulci (10) and corpus callosum anomalies (7). This study broadens the spectrum of CTNNB1-related syndrome, reporting a complex motor phenotype combining (i) gait disturbances related to dystonic or non-dystonic hypertonia and unsteadiness, sometimes associated to dystonia in other body parts (ii) possible deterioration of motor achievements over the course of the disease (iii) an exaggerated startle reflex. New non-specific brain anomalies are precisely described. Our work underscores the need for registries and longitudinal studies to refine characterization and guide future therapies.

#4

Identification of potential ferroptosis-related biomarkers in proliferative vitreoretinopathy based on machine learning.

Frontiers in molecular biosciences2026

Proliferative vitreoretinopathy (PVR) is a blinding retinal condition often linked to retinal detachment, eye trauma, and complications following intraocular surgery. Although oxidative stress and epithelial-mesenchymal transition (EMT) are well-recognized contributors to PVR pathogenesis, whether ferroptosis-related pathways are involved in this process remains unclear. Differentially expressed genes (DEGs) were identified from the GSE28133 dataset and intersected with ferroptosis-related genes curated from FerrDb to obtain ferroptosis-related differentially expressed genes (FRDGs). Functional enrichment analyses, protein-protein interaction network construction, and machine learning approaches (LASSO regression and SVM-RFE) were applied to identify key candidate genes. Immune infiltration was analyzed using CIBERSORT. Experimental validation was performed using an in vitro EMT model of retinal pigment epithelial cells and a rabbit PVR model. Functional enrichment analyses indicated that FRDGs were mainly involved in wound healing, tissue remodeling, oxidative stress responses, and ferroptosis-related pathways. TIMP1 and STAT3 were identified as ferroptosis-associated candidate genes with strong discriminative ability between PVR and control samples in the discovery dataset. Immune infiltration analysis revealed distinct immune cell profiles in PVR samples and significant correlations between TIMP1 and STAT3 expression and multiple immune cell subsets. Experimental validation confirmed upregulation of TIMP1 and STAT3 in the EMT model. In addition, Western blot analysis demonstrated significantly increased GPX4 protein expression in retinal tissues from the rabbit PVR model compared with controls. This study identifies TIMP1 and STAT3 as ferroptosis-associated candidate genes in proliferative vitreoretinopathy and highlights potential links among ferroptosis-related regulatory pathways, immune microenvironment alterations, and PVR pathogenesis. These findings provide a foundation for further mechanistic studies to clarify the role of ferroptosis in PVR.

#5

Sub-Internal Limiting Membrane Hemorrhage: Molecular Microenvironment and Review of Treatment Modalities.

International journal of molecular sciences2026 Jan 29

Sub-internal limiting membrane (sub-ILM) hemorrhage is a distinct preretinal bleeding entity in which blood accumulates between the ILM and the retinal nerve fiber layer (RNFL), forming a sharply confined compartment. The ILM's low permeability and lack of immune cell access create a stagnant microenvironment in which erythrocyte lysis leads to the accumulation of hemoglobin, heme, and iron, promoting the generation of reactive oxygen species. This oxidative burden poses a direct risk to retinal ganglion cells and Müller cell endfeet. Spectral-domain optical coherence tomography (SD-OCT) enables precise identification of sub-ILM blood through its characteristic dome-shaped elevation and hyperreflective contents, distinguishing it from subhyaloid and vitreous hemorrhage. Management options include observation, neodymium-doped yttrium-aluminum-garnet (Nd: YAG) laser membranotomy, pneumatic displacement, and pars plana vitrectomy (PPV). While small, extrafoveal hemorrhages may resolve spontaneously, prolonged blood entrapment is associated with increased retinal toxicity, tractional changes, and proliferative vitreoretinopathy (PVR). Early intervention generally results in faster clearance and improved visual outcomes, particularly for dense or foveal bleeding. Major gaps remain regarding cellular stress responses, biomarkers that predict irreversible damage, and the optimal timing of intervention. Standardized imaging criteria and evidence-based management algorithms are needed to guide individualized treatment.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC1.645 artigos no totalmostrando 197

2026

Letter to Editor: Correspondence regarding article "Real world efficacy of intravitreal methotrexate for managing proliferative vitreoretinopathy in recurrent rhegmatogenous retinal detachment".

Retina (Philadelphia, Pa.)
2026

All-Trans Retinoic Acid Modulates MicroRNA-129-5p/Hypoxia-Inducible Factor-1α/Vascular Endothelial Growth Factor Signaling and Suppresses Ets-1 in Retinal Pigment Epithelial ARPE-19 Cells.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
2026

KIF11 prevents retinal endothelial ferroptosis in familial exudative vitreoretinopathy by inhibiting phosphorylation-driven PRDX1 phase separation.

Nature communications
2026

The Inhibitory Effects of a Peripherally Restricted CB1 Receptor Antagonist on Myofibroblast Transdifferentiation of Human Retinal Pigment Epithelial Cells.

Cells
2026

Aberrant angiogenesis, inflammation, and fibrosis in pediatric vitreoretinal surgical diseases.

Survey of ophthalmology
2026

Association Between Iris Manipulation during Phacovitrectomy for Retinal Detachment Repair and Proliferative Vitreoretinopathy.

Retina (Philadelphia, Pa.)
2026

Risk factors for early emulsification of silicone oil after surgery for rhegmatogenous retinal detachment.

Indian journal of ophthalmology
2026

Dragging the macula: a comet‑like falciform retinal fold in NDP‑related familial exudative vitreoretinopathy in a child.

Eye (London, England)
2026

Olink proteomics profiling platform reveals inflammatory protein biomarkers in vitreous with different degrees of proliferative vitreoretinopathy.

Eye (London, England)
2026

Advancing perspectives on proliferative vitreoretinopathy: Updates in experimental research and emerging clinical treatments.

Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)
2026

Prophylactic chorioretinectomy in deadly weapon-related open globe injuries.

Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES
2026

CTNNB1-related disorders: clinical and radiological contributions from a French cohort.

Frontiers in neurology
2026

Novel nonsense variant of KIF11 in a patient with MCLMR.

Human genome variation
2026

A diabetes-induced change of MDM2 SNP309T→G contributes to aberrant retinal angiogenesis.

Diabetologia
2026

Vaccinia-related kinase 1/snail family transcriptional repressor 1 regulates epithelial-mesenchymal transition and inflammation in proliferative vitreoretinopathy.

International journal of ophthalmology
2026

From fibrotic mechanisms to clinical translation: the drug therapy revolution and delivery system breakthrough in proliferative vitreoretinopathy.

Frontiers in immunology
2026

Identification of potential ferroptosis-related biomarkers in proliferative vitreoretinopathy based on machine learning.

Frontiers in molecular biosciences
2026

Misdiagnosis in Referrals for Advanced Retinopathy of Prematurity.

Ophthalmology. Retina
2026

Post-vitrectomy Macular Edema: Shedding Light on Incidence and Risk Factors.

Ophthalmology and therapy
2026

Luteolin mitigates proliferative vitreoretinopathy through inhibition of ERK1/2 signaling and epithelial-mesenchymal transition.

Frontiers in pharmacology
2026

Selective Removal of Exposed Retinal Pigment Epithelium in Eyes With Extensive Retinal Loss to Prevent Proliferative Vitreoretinopathy.

Retinal cases & brief reports
2026

Novel CAPN5 mutation associated with bilateral retinal vasculopathy, peripheral non-perfusion, and a tractional retinal detachment in a 2-month-old girl.

Retinal cases & brief reports
2026

Sub-Internal Limiting Membrane Hemorrhage: Molecular Microenvironment and Review of Treatment Modalities.

International journal of molecular sciences
2026

Therapeutics for Management of Proliferative Vitreoretinopathy Related to Rhegmatogenous Retinal Detachment: A Network Meta-Analysis.

Retina (Philadelphia, Pa.)
2026

Characteristics and Vitreoretinal Management of Retinal Detachment in Eyes after Penetrating Keratoplasty in a 10-Year Study.

Retina (Philadelphia, Pa.)
2026

[Scleral buckling for rhegmatogenous retinal detachment-The value of buckle procedures in modern retinal surgery].

Die Ophthalmologie
2026

Bortezomib Inhibits Cellular Proliferation and Inflammation in a Mouse Model of Proliferative Vitreoretinopathy.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
2026

Drug strategies for the treatment and prevention of proliferative vitreoretinopathy: an overview of innovative treatment concepts.

International ophthalmology
2026

Can Aqueous Proteomics Predict the Recurrence of Rhegmatogenous Retinal Detachment?

Retina (Philadelphia, Pa.)
2026

Patient-Reported Outcomes after Surgery for Proliferative Vitreoretinopathy: Post hoc Analysis of a Randomized Controlled Trial.

Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde
2026

Candidate Interaction Partners of Calpain-5 Suggest Clues to Its Involvement in Neovascular Inflammatory Vitreoretinopathy.

Cells
2026

APRI and FIB-4 indices as systemic fibrosis markers in proliferative vitreoretinopathy.

BMC ophthalmology
2026

Analysis of the Correlation Between Prognostic Nutritional Index and Diabetic Retinopathy in Patients with Diabetes.

Endocrine, metabolic & immune disorders drug targets
2026

Continuous perfluorocarbon liquid infusion in giant retinal tear retinal detachment repair.

International ophthalmology
2026

Proliferative vitreoretinopathy-induced central retinal artery occlusion.

Journal francais d'ophtalmologie
2026

Rhegmatogenous retinal detachment in gyrate atrophy: a case report and review of literature.

Documenta ophthalmologica. Advances in ophthalmology
2026

Outcomes and predictive factors in scleral buckle surgery for rhegmatogenous retinal detachments.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
2026

Scleral Penetration by a Cryoprobe in Primary Buckling Surgery for Traumatic Retinal Detachment: A Case Report.

Case reports in ophthalmology
2026

Neuro-ophthalmic disorders resulting from defects in the gamma tubulin ring complex: a clinically oriented review.

Ophthalmic genetics
2025

Two distinctly located primary orbital melanomas following evisceration for congenital corneal staphyloma: a case report and brief literature review.

Frontiers in medicine
2026

MIF inhibition attenuates proliferative vitreoretinopathy pathogenesis and protects the eye in preclinical model.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
2025

Successful Removal of Subretinal Silicone Oil Using a Vitreous Fluid Control Kit: A Case Report.

Cureus
2026

A TGFB2/TNF-induced in vitro model of proliferative vitreoretinopathy (PVR) using ARPE-19 cells confirms nicotinamide as an inhibitor of EMT and VEGFA secretion.

PloS one
2025

Incidence and Risk Factors of Elevated Intraocular Pressure Following Vitrectomy Surgery in Rhegmatogenous Retinal Detachment in a Tertiary Hospital in Northern Malaysia.

Cureus
2026

A novel variant p.Y250C of FZD4 influences Norrine/β-catenin signaling pathway that associates with familial exudative vitreoretinopathy (FEVR).

Scientific reports
2026

Sequestration and Persistence of Methotrexate Bubbles within Silicone Oil Tamponade Following Pars Plana Vitrectomy.

Retinal cases & brief reports
2026

Subretinal fluid in rhegmatogenous retinal detachment: potential biomarkers and therapeutic targets for proliferative vitreoretinopathy.

International journal of ophthalmology
2026

Early and Pronounced PVR Reaction After Revitrectomy With Allogeneic Platelet Concentrate in Persistent Macular Hole.

Case reports in ophthalmological medicine
2026

Evaluation of oxidative stress and antioxidant system in the pathogenesis of proliferative vitreoretinopathy.

European journal of ophthalmology
2026

Surgical approach to ocular complications of Marfan syndrome.

Current opinion in ophthalmology
2026

An induced pluripotent stem cell line (SJTUXHi003-A) derived from a patient with copy number variation in the gene LRP5 causing familial exudative vitreoretinopathy.

Stem cell research
2026

Short-Term Perfluoro-N-Octane Tamponade for Combined Penetrating Keratoplasty and Pars Plana Vitrectomy.

Retinal cases & brief reports
2026

RWC Update: Impact of Aflibercept 2 mg Biosimilars on Retinal Disease Management; Power of the Needle; Proliferative Vitreoretinopathy.

Ophthalmic surgery, lasers & imaging retina
2025

Outcomes of Retinectomy for Proliferative Vitreoretinopathy: Comparison of Phakic Eyes Without Lensectomy and Pseudophakic Eyes.

Journal of vitreoretinal diseases
2025

Early Onset High Myopia and Severe Anisometropia Associated With Familial Exudative Vitreoretinopathy of Irregular Dominant Inheritance in 11 Chinese Families: Analysis of Refraction Features and Pathogenic Variations.

Genetics research
2026

Comparative analysis of activation of macrophages/microglia in diabetic retinopathy and Familial Exudative Vitreoretinopathy.

Biochemistry and biophysics reports
2025

Effect of 3',4'-Dihydroxyflavonol Eye Drops in a Rat Model of Dispase-Induced Proliferative Vitreoretinopathy.

Antioxidants (Basel, Switzerland)
2025

Amniotic Membrane Plug for Choroidal Hole and Epiciliary Membrane Removal: A Novel Surgical Rescue for Chronic Hypotony After Open Globe Injury.

Retinal cases & brief reports
2026

Bioinspired Proteome-Engineered Hydrogels as Vitreous Substitutes for Preserving Intraocular Homeostasis.

Advanced healthcare materials
2025

A Novel Ab Interno Approach for Traumatic Posterior Globe Perforation: Sutureless Closure With a Single-Layer Human Amniotic Membrane Plug.

Cureus
2026

Sphingosine-1-phosphate receptor 2 inhibition ameliorates familial exudative vitreoretinopathy models.

The Journal of biological chemistry
2025

A novel accessible in vitro model of proliferative vitreoretinal diseases shows facilitated epithelial mesenchymal transition through aquaporin-1.

Scientific reports
2025

Encircling scleral buckling as sole therapy for retinal detachment and neovascularization in familial exudative vitreo retinopathy.

European journal of ophthalmology
2025

Rhegmatogenous retinal detachment associated with spontaneous suprachoroidal hemorrhage in high myopia patients: two case reports and systematic review.

International ophthalmology
2025

[Molecular diagnostic biomarkers of subretinal fluid in assessing the severity and prognosis of rhegmatogenous retinal detachment].

Vestnik oftalmologii
2025

Loss of a primary cilia protein ARL13B promotes TGFβ-1 induced EMT of RPE in proliferative vitreoretinopathy via increasing Smad3 expression.

Frontiers in cell and developmental biology
2026

Deletion of versican V0/V2 isoforms in mice leads to retinal dysplasia.

Experimental eye research
2025

Large-sized human amniotic membrane patching-assisted vitrectomy for the management of postoperative proliferative vitreoretinopathy in complex rhegmatogenous retinal detachments.

Retina (Philadelphia, Pa.)
2026

Analysis of familial exudative vitreoretinopathy (FEVR) cases in the UK 100 000 genomes project increases diagnostic rate and implicates heterozygous CTNND1 mutations in FEVR.

Journal of medical genetics
2025

A novel use of the Finesse Flex Loop in retinal detachment with rolled edge of retinal tear.

American journal of ophthalmology case reports
2025

Evaluation of serum YKL-40 and Galectin-3 as predictive biomarkers for proliferative vitreoretinopathy in rhegmatogenous retinal detachment: a prospective comparative study.

BMC ophthalmology
2026

MeCP2 suppresses ferroptosis to drive EMT in retinal pigment epithelial cells: Implications for PVR pathogenesis.

Molecular medicine reports
2025

A Novel Frameshift Variant in KIF11 Causes Autosomal Dominant Familial Exudative Vitreoretinopathy in a Chinese Family.

Genetic testing and molecular biomarkers
2025

Extraction of Magnetic Intraocular Foreign Bodies Using a Novel Magnetic Foreign Body Extractor: 2 Cases.

Case reports in ophthalmology
2025

Retinal detachment risk in a cohort of von hippel-lindau patients at a Major U.S. tertiary care facility.

AJO international
2025

Clinical Characteristics and Surgical Outcomes of Bilateral Sequential Rhegmatogenous Retinal Detachment.

Journal of clinical medicine
2025

Nanotechnology-Based Delivery Systems and Retinal Pigment Epithelium: Advances, Targeting Approaches, and Translational Challenges.

Biomolecules
2025

Structure-Activity Relationships of N-Acyl Dopamines in Inhibiting Myofibroblast Transdifferentiation of Retinal Pigment Epithelial Cells.

Biomolecules
2025

High-Dimensional Immune Profiling of Human Retinal Detachment Samples Using Spectral Flow Cytometry: A Protocol for Intraocular Immunotyping.

Methods and protocols
2025

Risk factors for postoperative blindness in primary rhegmatogenous retinal detachment: insights from first presentation to a tertiary center in China.

International journal of ophthalmology
2026

A novel TSPAN12 mutation causing retinitis pigmentosa-like appearance of familial exudative vitreoretinopathy.

Ophthalmic genetics
2025

Late Reactivation of Retinopathy in a Treatment-Naive Female Adult Patient With History of Prematurity and ZNF408 Mutation.

Journal of vitreoretinal diseases
2025

KIF11 variants in familial exudative vitreoretinopathy leading to mTORC1 overactivation and impaired cell cycle progression.

Human genomics
2025

Analysis of full-term neonatal eye disease screening results and trends from 2016 to 2023.

Scientific reports
2025

Schisis-Like Presentations of Familial Exudative Vitreoretinopathy Caused by FZD4 Mutations.

Journal of vitreoretinal diseases
2025

Macular edema after pars plana vitrectomy for primary rhegmatogenous retinal detachment: Incidence, morphology, and risk factors.

Oman journal of ophthalmology
2025

Retinal detachments due to large-outer retinal tear in acquired retinoschisis managed with adjunctive combinations of microscope-integrated and wide-field optical coherence tomography.

Oman journal of ophthalmology
2025

Feasibility of Multimodal Deep Learning for Automated Staging of Familial Exudative Vitreoretinopathy Using Color Fundus Photographs and Fluorescein Angiography.

Diagnostics (Basel, Switzerland)
2025

[A case of spontaneous lens absorption following cataract complication after vitrectomy combined with silicone oil tamponade].

[Zhonghua yan ke za zhi] Chinese journal of ophthalmology
2026

Hypoxia-induced regional heterogeneity in proliferative vitreoretinopathy: implications for targeted therapies.

The Journal of pathology
2025

Refractive Error Correction With Glasses in Congenital Ocular Fundus Anomalies: A Retrospective Series of 18 Children With Different Disease Entities Followed Up for More Than 10 Years.

Cureus
2025

Tricin inhibits the migration of human retinal pigment epithelium cells by suppressing the RUNX2-CYP1A1 axis and STAT3 pathway.

International journal of medical sciences
2025

Regulation and mechanism of chloride channels in proliferative vitreoretinopathy.

Medicine
2025

A novel variant in the FZD4 gene leading to familial exudative vitreoretinopathy: A case report and literature review.

Medicine
2025

Severe Exudative Vitreoretinopathy Secondary to Homozygous PCDH12 Mutations.

Retinal cases & brief reports
2026

EFFICACY AND VASCULAR REDEVELOPMENT OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR STAGE 2 EARLY-DIAGNOSED FAMILIAL EXUDATIVE VITREORETINOPATHY.

Retina (Philadelphia, Pa.)
2026

Outcomes of Complex PVR Retinal Detachment Repair With and Without Intravitreal Methotrexate at a Single Tertiary Care Center.

Ophthalmic surgery, lasers & imaging retina
2026

Effects of Early Nursing Intervention Based on the Theory of Planned Behavior in Patients With Nonproliferative Diabetic Retinopathy: A Quasi-experimental Study.

Asian nursing research
2025

The anti-inflammatory effects of dexamethasone implants in eyes with heavy silicone oil: a prospective study on vitrectomy for diabetic retinopathy.

Frontiers in endocrinology
2025

Macular Hole Closure Between Two Tamponades: A Case Report.

Cureus
2025

5' UTR variant in the NDP gene leads to incorrect splicing and familial exudative vitreoretinopathy.

Orphanet journal of rare diseases
2025

A NOVEL USE OF FINESSE FLEX LOOP FOR PROLIFERATIVE VITREORETINOPATHY.

Retinal cases & brief reports
2025

Rigid gas permeable contact lens correction for young children with special refractive errors.

Clinical & experimental optometry
2025

Internal Drainage of Subretinal Fluid Using 25/32 Gauge Cannula in Eyes with Rhegmatogenous Retinal Detachment.

Turkish journal of ophthalmology
2025

Three-dimensional heads-up pneumatic retinopexy with chandelier illumination for rhegmatogenous retinal detachment in eyes with mild media opacity: a prospective case series.

International ophthalmology
2025

Tacrolimus modulates the PI3K AKT mTOR pathway in retinal epithelial cells under inflammatory stress.

Scientific reports
2025

Axial Length Profiles in Inherited Retinal Diseases-A Genotypic and Phenotypic Analysis.

Investigative ophthalmology & visual science
2025

Intravitreal Methotrexate for the Treatment and Prevention of Proliferative Vitreoretinopathy in Pediatric Patients.

Ophthalmic surgery, lasers & imaging retina
2025

Rhegmatogenous Retinal Detachment in Stickler Syndrome: A Systematic Review and Meta-Analysis.

Ophthalmology. Retina
2026

Unveiling Endothelial Cell Expression Profiles in FEVR: Identification of Key Genes Associated With Pathological Neovascularisation in a FZD4M105V Mouse Model.

Clinical & experimental ophthalmology
2025

Altered pattern of proteolysis in rhegmatogenous retinal detachment by mining of N-termini datasets from vitreous humor proteome.

Scientific reports
2025

Five novel pathogenic FZD4 variants identified in familial exudative vitreoretinopathy.

Advances in ophthalmology practice and research
2026

KIF11-related MCLMR presenting with FEVR-like retinopathy: first report in an Indian child.

Ophthalmic genetics
2025

Mapping Macrophage Diversity in Coats' Disease: A Lipid-Associated Subset in the Pathogenesis of Exudative Retinopathy.

Investigative ophthalmology & visual science
2025

Initial clinical use of the intraocular endoscope holding robot in pars plana vitrectomy.

Japanese journal of ophthalmology
2025

Pathogenic mechanisms and treatment advances in proliferative vitreoretinopathy: A review.

Medicine
2025

A genotype to phenotype relationship of exudative vitreoretinopathy in Loeys-Dietz syndrome due to a pathogenic variant in TGFBR2.

Ophthalmic genetics
2026

Clinical Characteristics and Long-term Visual Prognosis of Familial Exudative Vitreoretinopathy.

American journal of ophthalmology
2025

Outcomes of Pars Plana Vitrectomy in Complicated Retinal Detachment Secondary to Retinal Capillary Hemangioblastoma.

Medicina (Kaunas, Lithuania)
2026

Methotrexate-Loaded Liposomal Formulation Enables 6-Week Sustained Intraocular Therapeutic Drug Release in a Porcine Model.

Advanced healthcare materials
2025

Role of PPV in Advanced Retinal Hemangioblastoma-A Systematic Review.

International ophthalmology clinics
2026

Cellular-Level Assessment of Macular Development in Patients With Familial Exudative Vitreoretinopathy Using Multimodal Imaging: A Prospective Cohort Study.

American journal of ophthalmology
2025

Esculetin inhibits TGF-β2-induced proliferation and epithelial-mesenchymal transition of retinal pigment epithelial cells.

International ophthalmology
2026

Effect of methotrexate in preventing retinal detachment after proliferative vitreoretinopathy surgery: A systematic review and meta-analysis.

Survey of ophthalmology
2025

Retinal detachment in Nigerians: a multicentre cross-sectional study on demographics, risk factors for blindness and surgical outcomes in a developing country.

BMJ open
2026

EXCISION OF EXTENSIVE SUBRETINAL FIBROSIS ASSOCIATED WITH RHEGMATOGENOUS RETINAL DETACHMENTS IN PATIENTS WITH FAMILIAL EXUDATIVE VITREORETINOPATHY.

Retina (Philadelphia, Pa.)
2026

DIRECT POSTERIOR RETINAL INJURY CAUSED BY INTRAVITREAL INJECTIONS: Management and Outcomes From a Vitreoretinal Perspective.

Retina (Philadelphia, Pa.)
2025

Management and Surgical Outcomes of Tractional Retinal Detachment Associated With Ocular Syphilis.

Ophthalmic surgery, lasers & imaging retina
2025

Clinical Course of Iris Retraction Syndrome Associated With Rhegmatogenous Retinal Detachment: A Report of Three Cases.

Cureus
2026

HEAVY VERSUS STANDARD SILICONE OIL TAMPONADE IN PRIMARY RETINAL DETACHMENT SURGERY: A Systematic Review and Meta-Analysis.

Retina (Philadelphia, Pa.)
2025

Single-cell transcriptome combined with genetic tracing reveals a roadmap of fibrosis formation during proliferative vitreoretinopathy.

Proceedings of the National Academy of Sciences of the United States of America
2025

Migrasomes in Health and Disease: Insights into Mechanisms, Pathogenesis, and Therapeutic Opportunities.

Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
2025

Autologous Retinal Transplant in Refractory Macular Holes.

Journal of vitreoretinal diseases
2025

Influence of drainage retinotomy on anatomical and visual outcomes of pars plana vitrectomy for primary rhegmatogenous retinal detachment.

BMJ open ophthalmology
2026

CLINICAL AND DEMOGRAPHIC RISK FACTORS ASSOCIATED WITH RECURRENT AND FELLOW EYE RHEGMATOGENOUS RETINAL DETACHMENTS.

Retina (Philadelphia, Pa.)
2025

Pars Plana Vitrectomy Combined with Anti-VEGF Injections as an Approach to Treat Proliferative Diabetic Retinopathy.

Journal of clinical medicine
2025

Triamcinolone Acetonide-Assisted Visualization and Removal of Vitreous Cortex Remnants in Retinal Detachment: A Prospective Cohort Study.

Diagnostics (Basel, Switzerland)
2025

Traumatic Retinal Detachment: A Comparative Study in Closed and Open Globe Injuries.

Korean journal of ophthalmology : KJO
2025

Clinical implications of heavy silicon oil (Densiron®) endotamponade after pars plana vitrectomy: A systematic review and meta-analysis.

Survey of ophthalmology
2026

The human amniotic membrane in vitreoretinal surgery: Applications, outcomes and limitations.

Survey of ophthalmology
2025

Mammalian Target Rapamycin Inhibition as a Therapeutic Target for Prevention of Proliferative Vitreoretinopathy.

JAMA ophthalmology
2025

Familial Exudative Vitreoretinopathy in a Patient with Jacobsen Syndrome: A Case Report.

Korean journal of ophthalmology : KJO
2025

The efficacy of the three-port bimanual technique for direct perfluorocarbon liquid-silicone oil exchange in vitrectomy for the treatment of advanced proliferative vitreoretinopathy.

BMC ophthalmology
2025

Bilateral tractional retinal detachments complicating hemolytic-uremic syndrome.

American journal of ophthalmology case reports
2026

Association of Low Serum Vitamin D Levels with Proliferative Vitreoretinopathy after Rhegmatogenous Retinal Detachment Repair.

Ophthalmology. Retina
2026

Optimizing the detection of vitreous cortex remnants: The underestimated role of triamcinolone concentration.

Survey of ophthalmology
2025

Retinal parameter analysis and diagnostic potentail exploration in familial exudative vitreoretinopathy using ultra-widefield fundus photography.

International journal of retina and vitreous
2025

Familial Exudative Vitreoretinopathy-Like Retinal Findings in Adams-Oliver Syndrome Type 2.

Clinical & experimental ophthalmology
2025

An analysis of LRP5 gene frequencies in infants with familial exudative vitreoretinopathy in Chongqing and Urumqi.

Medicine
2026

PROLIFERATIVE VITREORETINOPATHY AND OUTER RETINAL FOLDS IN RHEGMATOGENOUS RETINAL DETACHMENT: Insights Into Retinal Remodeling.

Retina (Philadelphia, Pa.)
2025

Diagnostic Accuracy of AI Models in Detecting Different Inherited Retinal Diseases: A Systematic Review and Meta-Analysis.

Translational vision science & technology
2025

Removal of subretinal strands without creating an intentional retinal hole: A case report.

American journal of ophthalmology case reports
2025

Beveled-tip Versus Flat-tip Vitrectomy Probe for Vitreous Cortex Remnants Removal in Vitrectomy for Rhegmatogenous Retinal Detachment.

Ophthalmic surgery, lasers & imaging retina
2025

Inflammatory Mechanisms in the Management and Treatment of Retinal Detachment.

Metabolites
2025

A multicenter study on rates and risk factors of proliferative vitreoretinopathy in a low-income economy.

PloS one
2025

Intracellular Signaling Pathways and Their Potential Targeting for Treatment of Ocular Posterior Segment Fibrosis.

Journal of ophthalmic & vision research
2025

Recurrent rhegmatogenous retinal detachment after primary vitrectomy by surgeons in training - incidence and predictive factors.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
2025

Disintegrin Rhodostomin Mutant Ameliorates the Severity of Experimental Proliferative Vitreoretinopathy by Suppressing Both Integrin αvβ3 and α5β1.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
2025

Removal of subretinal proliferative vitreoretinopathy: case series and literature review.

International journal of retina and vitreous
2025

CLINICAL OUTCOMES OF SCLERAL BUCKLING IN ELDERLY PATIENTS WITH RHEGMATOGENOUS RETINAL DETACHMENT: A Retrospective Cohort Study.

Retina (Philadelphia, Pa.)
2024

"Retinal Displacement Following Retinectomy in Complex Macula-Involving Recurrent Rhegmatogenous Retinal Detachment".

Retinal cases & brief reports
2026

Internal Limiting Membrane Flap and Insertion Techniques Improve Prognosis in Macular Hole-Associated Retinal Detachment.

Ophthalmology. Retina
2025

The Identification of Proteolytic Substrates of Calpain-5 with N-Terminomics.

International journal of molecular sciences
2025

Surgical Technique: Viscodissection for Managing Funnel Retinal Detachments.

Journal of clinical medicine
2025

Comparison of gas and silicone oil tamponades for inferior quadrant recurrence in patients undergoing pars plana vitrectomy for rhegmatogenous retinal detachment.

International ophthalmology
2025

REAL-WORLD EFFICACY OF INTRAVITREAL METHOTREXATE FOR MANAGING PROLIFERATIVE VITREORETINOPATHY IN RECURRENT RHEGMATOGENOUS RETINAL DETACHMENT.

Retina (Philadelphia, Pa.)
2025

Evaluation of Gene Expression and the Regulatory Role of microRNAs Related to the Mitogen-Activated Protein Kinase Signaling Pathway in Human Retinal Pigment Epithelial Cells Treated With Lipopolysaccharide A and Tacrolimus.

Mediators of inflammation
2025

The MDM2-p53 axis regulates norrin/frizzled4 signaling and blood-CNS barrier function.

Science signaling
2025

The diagnostic value of ultra-widefield fundus imaging technology in early familial exudative vitreoretinopathy.

Ophthalmic genetics
2025

Distinct structural mechanisms of LGR4 modulation by Norrin and RSPOs in Wnt/β-catenin signaling.

Nature communications
2025

Phenotyping and genotyping FEVR: Molecular genetics, clinical and imaging features, and therapeutics.

Progress in retinal and eye research
2025

Cannabis Use and Proliferative Vitreoretinopathy Risk Reduction.

JAMA ophthalmology
2025

Long-Term Cannabis Use and Risk of Postoperative Proliferative Vitreoretinopathy.

JAMA ophthalmology
2025

[Clinical characteristics and surgical outcomes of pediatric retinal detachment associated with Stickler syndrome].

[Zhonghua yan ke za zhi] Chinese journal of ophthalmology
2025

Dual-Crosslinked Betaine-Based Amphiphilic Hydrogel as a Promising Vitreous Substitute: Anti-Adhesion, Anti-Fouling, and Anti-Cell Proliferation.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
2025

Vitreous Proteome in Combined Rhegmatogenous Retinal and Choroidal Detachment.

Retina (Philadelphia, Pa.)
2026

Internal Limiting Membrane Peeling for Grade C Proliferative Vitreoretinopathy: An International Multicenter Study.

Ophthalmology. Retina
2025

Therapeutic potential of artesunate in retinal diseases: from mechanism to clinical applications.

International journal of ophthalmology
2025

Liposome Encapsulation Enhances Ripasudil Therapeutic Efficacy Against Proliferative Vitreoretinal Diseases: Implications in Advanced Ocular Treatment.

Investigative ophthalmology & visual science
2025

Tacrolimus Modulates TGF-β Signaling-Related Genes and MicroRNAs in Human Retinal Pigment Epithelial Cells Activated by Lipopolysaccharide.

International journal of molecular sciences
2025

Commonalities between fibrotic and inflammatory mechanisms in proliferative vitreoretinopathy and proliferative diabetic retinopathy.

Experimental eye research
2025

Visual and surgical outcomes of retinal detachment after Lens removal for ectopia lentis in pediatric patients with Marfan syndrome.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
2025

DAPL1 inhibits epithelial-mesenchymal transition of retinal pigment epithelial cells by regulating the TGF-β/MITF pathway.

Experimental eye research
2025

Genotypic Distribution and Clinical Correlations in Familial Exudative Vitreoretinopathy: A Single-Center Study.

Ophthalmology science
2025

Therapeutic effect of suprachoroidal viscoelastic injection combined with 532 laser photocoagulation in treating rhegmatogenous retinal detachment.

BMC ophthalmology
2025

Etiology of retinal detachment and comparison of visual outcome after pars plana vitrectomy and scleral buckling surgical procedures.

BMC ophthalmology
2025

Non-surgical interventions for proliferative vitreoretinopathy-a systematic review.

Eye (London, England)
2025

Novel KIF11 Mutation Associated with Microcephaly, Chorioretinopathy and Impaired Intellectual Development: 20 Years of Follow-Up.

Children (Basel, Switzerland)
2025

360° LASER VERSUS LOCALIZED RETINOPEXY IN THE SURGICAL MANAGEMENT OF PRIMARY RHEGMATOGENOUS RETINAL DETACHMENT USING PARS PLANA VITRECTOMY.

Retina (Philadelphia, Pa.)
2025

A case of congenital heart defects and familial exudative vitreoretinopathy caused by activation of a cryptic splice donor in NOTCH1.

BMC medical genomics
2025

Retinal vascularization from a new angle: A systematic review of temporal retinal vessel angles in familial exudative vitreoretinopathy.

Retina (Philadelphia, Pa.)
2025

DYRK1A syndrome presenting with a familial exudative vitreoretinopathy (FEVR)-like retinovascular phenotype.

Ophthalmic genetics
2025

Incidence and risk factors for recurrence after surgical treatment of rhegmatogenous retinal detachment: a retrospective cohort study.

International journal of retina and vitreous
2025

Pregnancy and Diabetic Retinopathy: A Report From the All of Us Research Program.

Ophthalmology. Retina
2025

Assessing the therapeutic potential of astaxanthin in experimental proliferative vitreoretinopathy models.

European journal of ophthalmology
2025

Multikinase inhibition-mediated proliferative vitreoretinopathy therapy by nanoparticles in rabbits.

Molecular vision
2025

Vitreous proteomics in rhegmatogenous retinal detachment and proliferative vitreoretinopathy.

Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
Ver todos os 1.645 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Vitreorretinopatia.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Vitreorretinopatia

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. KIF11 prevents retinal endothelial ferroptosis in familial exudative vitreoretinopathy by inhibiting phosphorylation-driven PRDX1 phase separation.
    Nature communications· 2026· PMID 41872221mais citado
  2. The Inhibitory Effects of a Peripherally Restricted CB1 Receptor Antagonist on Myofibroblast Transdifferentiation of Human Retinal Pigment Epithelial Cells.
    Cells· 2026· PMID 41827852mais citado
  3. CTNNB1-related disorders: clinical and radiological contributions from a French cohort.
    Frontiers in neurology· 2026· PMID 41789168mais citado
  4. Identification of potential ferroptosis-related biomarkers in proliferative vitreoretinopathy based on machine learning.
    Frontiers in molecular biosciences· 2026· PMID 41743358mais citado
  5. Sub-Internal Limiting Membrane Hemorrhage: Molecular Microenvironment and Review of Treatment Modalities.
    International journal of molecular sciences· 2026· PMID 41683760mais citado
  6. "Unexpected athalamia after scleral buckling for retinal detachment in a pediatric Marfan patient with scleral-fixated intraocular lens".
    Retin Cases Brief Rep· 2026· PMID 41995746recente
  7. Comparison of per operative methotrexate infusion with postoperative intra silicon oil methotrexate injections for prevention of proliferative vitreoretinopathy development after vitrectomy for rhegmatogenous retinal detachment repair.
    Pak J Med Sci· 2026· PMID 41994389recente
  8. Densiron 68 Tamponade Duration and Redetachment Risk after Removal in Inferior PVR-associated Retinal Detachment.
    Ophthalmologica· 2026· PMID 41984749recente
  9. Novel variant c.428T>C in FZD4 gene in a pedigree affected by familial exudative vitreoretinopathy: clinical, functional, and structural characterization.
    Ophthalmic Genet· 2026· PMID 41981389recente
  10. The Eye-Heart Connection: Exploring the unique ocular features in tetralogy of Fallot.
    Rom J Ophthalmol· 2025· PMID 41971210recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:98668(Orphanet)
  2. MONDO:0020246(MONDO)
  3. GARD:19539(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q7937231(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Vitreorretinopatia

ORPHA:98668 · MONDO:0020246
Ensaios
8 ativos
MedGen
UMLS
C0344290
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades